SEC FORM 4
$7,514.08
Artiva Biotherapeutics, Inc. (ARTV)
Sale of 1,099 shares at $6.8372 per share.
Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001193125-26-415528 · filed 2026-10-06 · View filing →